Manganese superoxide dismutase gene Ala-9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 8, 2008, Pages 1844-1847

  Kang, Seung Gul ^a   Choi, Jung Eun ^a   An, Hyonggin ^a   Park, Young Min ^b   Lee, Heon Jeong ^a   Han, Changsu ^a   Kim, Yong Ku ^a   Kim, Seung Hyun ^a   Cho, Sung Nam ^c   Joe, Sook Haeng ^a   Jung, In Kwa ^a   Kim, Leen ^a   Lee, Min Soo ^a  

^a Korea University College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Bugok National Hospital   (South Korea)

Author keywords

Abnormal involuntary movements; Manganese superoxide dismutase; Polymorphism; Schizophrenia; Tardive dyskinesia

Indexed keywords

ALANINE; MANGANESE SUPEROXIDE DISMUTASE; NEUROLEPTIC AGENT; VALINE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME POLYMORPHISM; FEMALE; GENETIC RISK; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SOUTH KOREA; TARDIVE DYSKINESIA;

ADULT; ALANINE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KOREA; LOGISTIC MODELS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SUPEROXIDE DISMUTASE; VALINE;

EID: 56449089003     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.08.013     Document Type: Article

References (38)

1. Akyol O., Yanik M., Elyas H., Namli M., Canatan H., Akin H., et al. Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 123-131
2. Bakker P.R., van Harten P.N., and van Os J. Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions. Mol Psychiatry 13 (2008) 544-556
3. Brown K., Reid A., White T., Henderson T., Hukin S., Johnstone C., et al. Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia. Biol Psychiatry 43 (1998) 863-867
4. Cadet J.L., and Kahler L.A. Free radical mechanisms in schizophrenia and tardive dyskinesia. Neurosci Biobehav Rev 18 (1994) 457-467
5. Cavalli-Sforza L.L., Menozzi P., and Piazza A. The History and Geography of Human Genes (1994), Princeton University Press, Princeton, N.J.
6. Elkashef A.M., and Wyatt R.J. Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E. Schizophr Bull 25 (1999) 731-740
7. Fridovich I. Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol 41 (1974) 35-97
8. Guy W. Abnormal Involuntary Movement Scale (AIMS). ECDEU Assessment Manual for Psychopharmacology (1976), U. S. Dept. of Health, Education, and Welfare 534-537
9. Halliwell B. Antioxidants and human disease: a general introduction. Nutr Rev 55 (1997) S44-S49 [discussion S9-52]
10. Han O.S., and Hong J.P. Structured Clinical Interview for DSM-IV Axis I Disorder-Korean Version (2000), Hana Medical Publishing, Seoul
11. Hiroi S., Harada H., Nishi H., Satoh M., Nagai R., and Kimura A. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun 261 (1999) 332-339
12. Hitzeroth A., Niehaus D.J., Koen L., Botes W.C., Deleuze J.F., and Warnich L. Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 664-672
13. Hori H., Ohmori O., Shinkai T., Kojima H., Okano C., Suzuki T., et al. Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia. Neuropsychopharmacology 23 (2000) 170-177
14. Jeste D.V., and Caligiuri M.P. Tardive dyskinesia. Schizophr Bull 19 (1993) 303-315
15. Kane J.M., Woerner M., and Lieberman J. Tardive dyskinesia: prevalence, incidence, and risk factors. J Clin Psychopharmacol 8 (1988) 52S-56S
16. Kang S.G., Choi J.E., An H., Lim S.W., Lee H.J., Han C., et al. No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1545-1548
17. Kang S.G., Choi J.E., Park Y.M., Lee H.J., Han C., Kim Y.K., et al. Val158Met polymorphism in the catechol-O-methyltransferase (COMT) gene is not associated with tardive dyskinesia in schizophrenia. Neuropsychobiology 57 (2008) 22-25
18. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13 (1987) 261-276
19. Lee H.J. Pharmacogenetic studies investigating the adverse effects of antipsychotics. Psychiatr Invest 4 (2007) 66-75
20. Lee H.J., Kang S.G., Choi J.E., Paik J.W., Kim Y.K., Kim S.H., et al. No association between dopamine D4 receptor gene - 521 C/T polymorphism and tardive dyskinesia in schizophrenia. Neuropsychobiology 55 (2007) 47-51
21. Lee H.J., Kang S.G., Paik J.W., Lee M.S., Cho B.H., Park Y.M., et al. No evidence for an association between G protein β3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia. Hum Psychopharmacol Clin Exp 22 (2007) 501-504
22. Lohr J.B., Kuczenski R., Bracha H.S., Moir M., and Jeste D.V. Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol Psychiatry 28 (1990) 535-539
23. Müller D.J., Schulze T.G., Knapp M., Held T., Krauss H., Weber T., et al. Familial occurrence of tardive dyskinesia. Acta Psychiatr Scand 104 (2001) 375-379
24. Pae C.U., Kim T.S., Patkar A.A., Kim J.J., Lee C.U., Lee S.J., et al. Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia. Psychiatry Res 153 (2007) 77-81
25. Rao A.V., and Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci 5 (2002) 291-309
26. Robinson B.H. The role of manganese superoxide dismutase in health and disease. J Inherit Metab Dis 21 (1998) 598-603
27. Rosengarten H., Schweitzer J.W., and Friedhoff A.J. Possible genetic factors underlying the pathophysiology of tardive dyskinesia. Pharmacol Biochem Behav 49 (1994) 663-667
28. Schooler N.R., and Kane J.M. Research diagnosis for tardive dyskinesia. Arch Gen Psychiatry 39 (1982) 486-487
29. Shale H., and Tanner C. Pharmacological options for the management of dyskinesias. Drugs 52 (1996) 849-860
30. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimizu Y., and Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 226 (1996) 561-565
31. Shimoda-Matsubayashi S., Hattori T., Matsumine H., Shinohara A., Yoritaka A., Mori H., et al. Mn SOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control. Neurology 49 (1997) 1257-1262
32. Tarsy D., and Baldessarini R.J. The pathophysiologic basis of tardive dyskinesia. Biol Psychiatry 12 (1977) 431-450
33. Tarsy D., and Baldessarini R.J. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?. Mov Disord 21 (2006) 589-598
34. Weinhold P., Wegner J.T., and Kane J.M. Familial occurrence of tardive dyskinesia. J Clin Psychiatry 42 (1981) 165-166
35. Yassa R., and Ananth J. Familial tardive dyskinesia. Am J Psychiatry 138 (1981) 1618-1619
36. Yassa R., and Jeste D.V. Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull 18 (1992) 701-715
37. Zhang Z., Zhang X., Hou G., Sha W., and Reynolds G.P. The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism. J Psychiatr Res 36 (2002) 317-324
38. Zhang Z.J., Zhang X.B., Hou G., Yao H., and Reynolds G.P. Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia. Psychiatr Genet 13 (2003) 187-192